Last €32.34 EUR
Change Today -0.76 / -2.31%
Volume 30.0
8AK On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 11:03 AM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - alkermes plc (8AK)

NameBoard RelationshipsTitleAge
Richard F. Pops 149 RelationshipsChairman of the Board and Chief Executive Officer52
Shane Cooke 20 RelationshipsPresident52
Floyd E. Bloom M.D.96 RelationshipsCo-Founder, Director and Member of Audit & Risk Committee77
James M. Frates 15 RelationshipsChief Financial Officer, Principal Accounting Officer, Senior Vice President and Treasurer47
Gordon G. Pugh No RelationshipsChief Operating Officer, Chief Risk Officer and Senior Vice President56

Board Members - alkermes plc (8AK)

NameBoard RelationshipsPrimary CompanyAge
Richard F. Pops 149 RelationshipsAlkermes plc52
Floyd E. Bloom M.D.96 RelationshipsAlkermes plc77
Paul J. Mitchell 7 RelationshipsAlkermes plc62
David Westbrook Anstice 135 RelationshipsAlkermes plc66
Wendy L. Dixon Ph.D.63 RelationshipsAlkermes plc59

Executive Committees* - alkermes plc (8AK)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteePaul J. Mitchell 7 Relationships3 Executives
Compensation CommitteeDavid Westbrook Anstice 135 Relationships3 Executives
Nominating CommitteeWendy L. Dixon Ph.D. 63 Relationships3 Executives
Corporate Governance CommitteeWendy L. Dixon Ph.D. 63 Relationships3 Executives
View 8AK Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €32.34 EUR -0.76

8AK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $61.82 USD +0.73
Cosmo Pharmaceuticals SpA SFr.184.60 CHF -3.00
Jazz Pharmaceuticals Plc $139.73 USD -1.65
Pacira Pharmaceuticals Inc/DE $92.00 USD +4.17
Salix Pharmaceuticals Ltd $131.91 USD -3.35
View Industry Companies
 

Industry Analysis

8AK

Industry Average

Valuation 8AK Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.2x
Price/Book 5.0x
Price/Cash Flow 134.8x
TEV/Sales 10.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.